Solventum Co. (NYSE:SOLV) Receives Consensus Recommendation of "Hold" from Analysts

Solventum Co. (NYSE:SOLV - Get Free Report) has been assigned an average recommendation of "Hold" from the ten analysts that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $79.86.

SOLV has been the topic of several recent research reports. Morgan Stanley lifted their price target on shares of Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, March 5th. Bank of America upped their target price on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a report on Wednesday, February 26th. Piper Sandler raised their price target on Solventum from $75.00 to $84.00 and gave the company a "neutral" rating in a research note on Friday, February 28th. The Goldman Sachs Group upped their price objective on Solventum from $63.00 to $71.00 and gave the stock a "sell" rating in a research note on Monday, March 3rd. Finally, Wells Fargo & Company upped their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th.

Solventum Stock Up 2.1 %

Shares of SOLV traded up $1.34 during mid-day trading on Friday, hitting $66.28. 299,603 shares of the company's stock were exchanged, compared to its average volume of 1,313,114. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum has a 52 week low of $47.16 and a 52 week high of $85.92. The company has a market cap of $11.47 billion and a PE ratio of 24.10. The company has a 50-day simple moving average of $73.04 and a 200 day simple moving average of $71.60.

Institutional Investors Weigh In On Solventum

A number of institutional investors have recently modified their holdings of the business. Modus Advisors LLC acquired a new position in shares of Solventum during the 4th quarter worth approximately $25,000. Clarity Asset Management Inc. acquired a new stake in Solventum during the fourth quarter worth approximately $25,000. Stonebridge Financial Group LLC bought a new position in Solventum during the 4th quarter worth $26,000. Raiffeisen Bank International AG acquired a new position in Solventum in the 4th quarter valued at $29,000. Finally, Crews Bank & Trust bought a new stake in shares of Solventum during the 4th quarter valued at $32,000.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.